EFNA response to the adoption of the UN Political Declaration on NCDs
As 2026 begins we (EFNA) reflect on and welcome the adoption of the UN Political Declaration on the prevention and control of noncommunicable diseases (NCDs) […]
READ MOREARCHIVE
ARCHIVE
Category: Press Releases
Clinical Trial into Psilocybin Therapy for Psychological Distress in Palliative Care, PsyPal, Receives Medical Ethical Authorisation, with Conditions
Key takeaways Clinical study authorisation milestone achieved: The Clinical Trial PsyPal has been authorised in the participating member states, with conditions. Sign up to the […]
READ MORE
EU Pharma Revision – Position Paper
Download the EFNA Position Statement On The EU Pharmaceutical Strategy Revision Recently, the European Commission published revision of the EU pharma legislation. A first in two […]
READ MOREEFNA hosts Advocacy Workshop for national patient groups
In 2015, the European Federation of Neurological Associations [EFNA], together with Pain Alliance Europe, will launch an MEP Interest Group on Brain, Mind and Pain […]
READ MORE“Out of Office” European Parliament event
Report highlights widespread variation in sick leave benefits across Europe Wednesday, February 19th at the European Parliament The Economist Intelligence Unit [EIU] presented […]
READ MORE